Advanced search
Publication Cover
Journal of Receptors and Signal Transduction Volume 38, 2018 - Issue 3
Submit an article Journal homepage
346
Views
7
CrossRef citations to date
0
Altmetric
Research Article

PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation

Tuyen N. M. HuaDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; ;Department of Global Medical Science, Institute of Lifestyle Medicine, Nuclear Receptor Research Consortium, Mitohormesis Research Center, Wonju College of Medicine, Yonsei University, Wonju, South KoreaView further author information
,
Jun NamkungDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; View further author information
,
Ai N. H. PhanDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; ;Department of Global Medical Science, Institute of Lifestyle Medicine, Nuclear Receptor Research Consortium, Mitohormesis Research Center, Wonju College of Medicine, Yonsei University, Wonju, South KoreaView further author information
,
Vu T. A. VoDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; ;Department of Global Medical Science, Institute of Lifestyle Medicine, Nuclear Receptor Research Consortium, Mitohormesis Research Center, Wonju College of Medicine, Yonsei University, Wonju, South KoreaView further author information
,
Min-Kyu KimDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; ;Department of Global Medical Science, Institute of Lifestyle Medicine, Nuclear Receptor Research Consortium, Mitohormesis Research Center, Wonju College of Medicine, Yonsei University, Wonju, South KoreaView further author information
,
Yangsik JeongDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; ;Department of Global Medical Science, Institute of Lifestyle Medicine, Nuclear Receptor Research Consortium, Mitohormesis Research Center, Wonju College of Medicine, Yonsei University, Wonju, South KoreaCorrespondence[email protected]
View further author information
&
Jong-Whan ChoiDepartment of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, South Korea; Correspondence[email protected]
View further author information
 show all
Pages 191-197 | Received 08 Jan 2018, Accepted 20 Apr 2018, Published online: 06 Jun 2018

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  • Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760–774.
  • Phan AN, Hua TN, Kim MK, et al. Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer. Oncotarget. 2016;7:54702–54713.
  • Krishnan A, Nair SA, Pillai MR. Biology of PPAR gamma in cancer: a critical review on existing lacunae. Curr Mol Med. 2007;7:532–540.
  • Kim J, Sato M, Choi JW, et al. Nuclear receptor expression and function in human lung cancer pathogenesis. PLoS One. 2015;10:e0134842.
  • Jeong Y, Xie Y, Lee W, et al. Research resource: diagnostic and therapeutic potential of nuclear receptor expression in lung cancer. Mol Endocrinol. 2012;26:1443–1454.
  • Wick M, Hurteau G, Dessev C, et al. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. Mol Pharmacol. 2002;62:1207–1214.
  • Wang Y, James M, Wen W, et al. Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice. Mol Cancer Ther. 2010;9:3074–3082.
  • Govindarajan R, Ratnasinghe L, Simmons DL, et al. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol. 2007;25:1476–1481.
  • Marchitti SA, Brocker C, Stagos D, et al. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 2008;4:697–720.
  • Xu X, Chai S, Wang P, et al. Aldehyde dehydrogenases and cancer stem cells. Cancer Lett. 2015;369:50–57.
  • Cheng P, Wang J, Waghmare I, et al. FOXD1-ALDH1A3 Signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res. 2016;76:7219–7230.
  • Kang JH, Lee SH, Hong D, et al. Aldehyde dehydrogenase is used by cancer cells for energy metabolism. Exp Mol Med. 2016;48:e272.
  • Reichert B, Yasmeen R, Jeyakumar SM, et al. Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. Mol Endocrinol. 2011;25:799–809.
  • Podvinec M, Kaufmann MR, Handschin C, et al. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol. 2002;16:1269–1279.
  • Kliewer SA, Umesono K, Noonan DJ, et al. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992;358:771–774.
  • Zhou BB, Peyton M, He B, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39–50.
  • Vasiliou V, Thompson DC, Smith C, et al. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact. 2013;202:2–10.
  • Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.
  • Han SW, Roman J. Anticancer actions of PPARgamma ligands: current state and future perspectives in human lung cancer. World J Biol Chem. 2010;1:31–40.
  • Cariou B, Charbonnel B, Staels B. Thiazolidinediones and PPARgamma agonists: time for a reassessment. Trends Endocrinol Metab. 2012;23:205–215.
  • Phan ANH, Vo VTA, Hua TNM, et al. PPARgamma sumoylation-mediated lipid accumulation in lung cancer. Oncotarget. 2017;8:82491–82505.
  • Shao C, Sullivan JP, Girard L, et al. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Clin Cancer Res. 2014;20:4154–4166.
  • Srivastava N, Kollipara RK, Singh DK, et al. Inhibition of cancer cell proliferation by PPARgamma is mediated by a metabolic switch that increases reactive oxygen species levels. Cell Metab. 2014;20:650–661.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.